For research use only
| Cat No. | ABC-X0310C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human NRAS (G12D) NIH/3T3 Cell Line is a useful tool for evaluating NRAS mutation-driven transformation and drug responses in cancer cell models.
Human NRAS (G12D) NIH/3T3 Cell Line is a genetically engineered fibroblast cell line stably expressing the G12D mutant of human NRAS. It is commonly used in oncogenic transformation studies and drug discovery.
Target
NRAS G12D is a gain-of-function mutation that disrupts GTPase activity, leading to constitutive pathway activation. It is frequently found in melanoma and acute myeloid leukemia.
AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0310C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Used for Ras signaling studies, this model helps evaluate the efficacy of Ras/MAPK pathway inhibitors and dissect mutation-specific responses.